Chemotherapy-related cognitive impairment: does integrating complementary medicine have something to add? Review of the literature
- 23 August 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 136 (1), 1-7
- https://doi.org/10.1007/s10549-012-2211-5
Abstract
Chemotherapy-related cognitive impairment is a phenomenon of cognitive decline that some patients experience during and after chemotherapy. The prevalence of chemotherapy-related cognitive impairment in cancer survivors ranges from 14 to 85 %. Memory loss and lack of concentration are the most frequent symptoms, often resulting in deterioration of daily functioning and a decreased quality of life. Despite ongoing research on chemotherapy-related cognitive impairment, a clear understanding of the underlying mechanisms of the neurotoxicity induced by chemotherapy and the factors that determine a patient's vulnerability are still lacking. We review current knowledge regarding the etiology of chemotherapy-related cognitive impairment, risk factors, conventional therapy, coping strategies, and potential complementary and integrative medicine treatments. Complementary and integrative medicine modalities that may improve chemotherapy-related cognitive impairment include mind-body techniques and acupuncture, as well as nutrition and herbal therapies. Studies on these modalities have not directly tested the hypothesis of modifying chemotherapy-related cognitive impairment and were done on different disorders of memory loss and lack of concentration. We recommend conducting further research on the potential role of complementary and integrative medicine modalities in the treatment and prevention of chemotherapy-related cognitive impairment.Keywords
This publication has 78 references indexed in Scilit:
- Longitudinal Assessment of Chemotherapy-Induced Structural Changes in Cerebral White Matter and Its Correlation With Impaired Cognitive FunctioningJournal of Clinical Oncology, 2012
- Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care responseJournal of Cancer Survivorship, 2009
- Chemotherapy-Related Cognitive ImpairmentClinical Journal of Oncology Nursing, 2009
- Neuropsychological studies in breast cancer: in search of chemobrainBreast Cancer Research and Treatment, 2008
- Chemobrain Is Real but May Need New NameJNCI Journal of the National Cancer Institute, 2008
- Chemotherapy and cognitive deficits: Mechanisms, findings, and potential interventionsPalliative & Supportive Care, 2007
- Candidate mechanisms for chemotherapy-induced cognitive changesNature Reviews Cancer, 2007
- Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients - evaluation of appropriate research design and methodology to measure symptomsBreast Cancer, 2005
- Neurophysiological Evaluation of Late Effects of Adjuvant High-dose Chemotherapy on Cognitive FunctionJournal of Neuro-Oncology, 2001
- Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose ChemotherapyJNCI Journal of the National Cancer Institute, 1998